Difference between revisions of "Carmustine (BCNU)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(delete regimens section)
m (also known as)
Line 1: Line 1:
 +
Also known as bischloroethylnitrosourea, BCNU.
 +
 
==General information==
 
==General information==
 
Class/mechanism: Nitrosourea, alkylates DNA and RNA, inhibits several key enzymatic processes by carbamoylation of amino acids in proteins.<ref name="insert">[http://packageinserts.bms.com/pi/pi_bicnu.pdf Carmustine (Bicnu) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/carmustine.pdf Carmustine (Bicnu) package insert (locally hosted backup)]</ref>
 
Class/mechanism: Nitrosourea, alkylates DNA and RNA, inhibits several key enzymatic processes by carbamoylation of amino acids in proteins.<ref name="insert">[http://packageinserts.bms.com/pi/pi_bicnu.pdf Carmustine (Bicnu) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/carmustine.pdf Carmustine (Bicnu) package insert (locally hosted backup)]</ref>
Line 4: Line 6:
 
<br>Extravasation: [[vesicant]]/[[irritant]]
 
<br>Extravasation: [[vesicant]]/[[irritant]]
  
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the package insert<ref name="insert"></ref>.  
+
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information<ref name="insert"></ref>.  
  
 
==Patient drug information==
 
==Patient drug information==

Revision as of 03:06, 6 April 2012

Also known as bischloroethylnitrosourea, BCNU.

General information

Class/mechanism: Nitrosourea, alkylates DNA and RNA, inhibits several key enzymatic processes by carbamoylation of amino acids in proteins.[1][2]
Route: IV
Extravasation: vesicant/irritant

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information[1].

Patient drug information

References